Home Infusion for Autoimmune Disease: Taking Control of Where You Get Treated

Millions of Americans living with autoimmune diseases receive regular infusion therapy. For many of them, the treatment location — a hospital outpatient center, an ambulatory clinic, or home — has as much impact on quality of life as the medication itself. Home infusion is available for a growing number of autoimmune conditions and drugs, and an increasing number of insurers now prefer it as the default site of care.

Autoimmune Conditions That Commonly Use Home Infusion

Autoimmune diseases are remarkably diverse, but they share a common thread: the immune system mistakenly attacks the body’s own tissues. When infusion therapy is part of the treatment plan, home infusion may be an option for patients who have demonstrated tolerance to their medication. The following conditions are among those most frequently treated with home infusion.

Neurological Autoimmune Conditions

• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): One of the most common home infusion diagnoses. Patients with stable CIDP often receive IVIG at home every 3 to 6 weeks for years or indefinitely.
• Multiple Sclerosis (MS): Drugs like Ocrevus, Tysabri, and Rituxan can be given at home for eligible patients. Home infusion for MS has become increasingly common.
• Myasthenia Gravis (MG): IVIG and newer therapies like Vyvgart (efgartigimod) are used for MG, with IVIG frequently administered at home for stable patients.
• Neuromyelitis Optica Spectrum Disorder (NMOSD): Rituximab infusions for NMOSD are sometimes given at home after initial doses are tolerated.

Rheumatologic and Gastrointestinal Conditions

• Rheumatoid Arthritis (RA): Infliximab (Remicade and biosimilars) is one of the most widely given home infusion drugs for RA.
• Crohn’s Disease and Ulcerative Colitis: Remicade has a long track record of safe home administration for inflammatory bowel disease. Remicade home infusion is well-established for patients with stable disease.
• Lupus (Systemic Lupus Erythematosus): Benlysta (belimumab) infusions can be administered at home for patients who have tolerated initial clinical infusions.
• Vasculitis: Rituximab is used for ANCA-associated vasculitis, and home infusion is possible after clinical stability is established.

Immunodeficiency

• Primary Immunodeficiency Diseases (PIDD): IVIG or subcutaneous immunoglobulin for PIDD has one of the longest histories of home infusion — many patients have been doing it at home for decades.

Which Drugs Are Routinely Given at Home

Not every infusion drug is equally suited to home administration. Here is a practical breakdown of the most common home infusion medications for autoimmune disease:

Drugs That Typically Require a Clinical Setting

Some autoimmune infusion therapies carry risks that make clinical supervision necessary:

• Lemtrada (alemtuzumab) for MS — REMS program, serious reaction risk
• Cyclophosphamide (Cytoxan) for lupus nephritis or vasculitis — chemotherapy agent requiring monitoring for acute toxicity
• First doses of most biologic infusions — regardless of the drug, the initial one to three infusions are almost always given in a clinical setting to establish tolerance

How to Ask About Transitioning to Home Infusion

Many autoimmune patients do not realize they can receive infusions at home, or they assume their doctor will bring it up if it is an option. In practice, patients often need to initiate the conversation themselves.

Here is a practical approach:

1. Document your stability. If you have been on the same infusion drug for 3 to 6 months or longer without serious reactions or dose changes, you have a strong case for home infusion.
2. Bring it up at your next appointment. A straightforward question works: “I’ve been tolerating my infusions well. Would I be a candidate for home infusion?”
3. Ask about logistics, not just permission. Sometimes the barrier is not medical but logistical — the doctor’s office may not have a relationship with a home infusion pharmacy, or the staff may not be familiar with the referral process. Offering to handle the insurance inquiry can move things along.
4. Call your insurance company. Ask whether your plan covers home infusion for your specific drug. Many plans have a site-of-care program that actively facilitates the transition.

The American College of Rheumatology and the American Academy of Neurology both recognize home infusion as appropriate for stable patients on established biologic therapies.

The Insurance Advantage

Here is something that surprises many patients: insurance companies increasingly want patients to receive infusions at home. The reason is cost. A single infusion of a biologic drug at a hospital outpatient department can cost an insurer two to five times more than the same infusion at home, due to facility fees and overhead charges.

This cost difference has led to a growing number of site-of-care optimization programs where insurers actively steer patients toward home infusion or freestanding infusion centers. For patients, this can mean:

• Lower copays and coinsurance at home compared to a hospital outpatient setting
• Faster prior authorization when the request is for home infusion
• In some cases, the insurer will not cover hospital-based infusion when a home alternative is available and medically appropriate

What to Expect From a Home Infusion Pharmacy

A home infusion pharmacy is not an ordinary pharmacy. It is a specialized healthcare operation that coordinates the medication, supplies, nursing, and clinical monitoring for infusion therapy delivered in the home. Here is what the process generally looks like:

1. Referral and benefits verification. The doctor sends an order to the pharmacy. The pharmacy verifies insurance coverage and obtains prior authorization.
2. Medication procurement and delivery. The pharmacy sources the drug (which may be a specialty biologic costing thousands of dollars) and ships it to the patient’s home with all necessary supplies.
3. Nurse scheduling. The pharmacy coordinates a registered nurse — often one who specializes in the patient’s specific therapy — to come to the home on infusion days.
4. Ongoing clinical management. The pharmacy tracks lab results, communicates with the prescribing doctor, manages dose adjustments, and provides 24/7 pharmacist access for patient questions.
5. Reauthorization. Insurance authorizations typically expire every 3 to 12 months. A good pharmacy handles reauthorization proactively so there is no gap in treatment.

Living with an autoimmune disease already demands enormous resilience. Choosing where infusion treatment happens is one area where patients can exercise real control. For those who are eligible, home infusion can reduce the burden of treatment, lower costs, and make a chronic condition feel a little more manageable — one infusion day at a time.

Learn more about the differences between treatment settings in the home infusion vs. infusion center comparison.